Showing results (851-860 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|March 16, 2020
Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular SurgeryConnie Kang, Susan J Keam, Matt Shirley, et al.
Clinical Drug Investigation|March 11, 2020
Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image StudyJörg Mahlich, Kerstin Olbrich, Adrian Wilk, et al.
Clinical Drug Investigation|January 24, 2019
Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy SubjectsMohammed Bouhajib, Zia Tayab
Clinical Drug Investigation|January 29, 2019
Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance DatabaseKeiko Hosohata, Ayaka Inada, Saki Oyama, et al.
Clinical Drug Investigation|December 8, 2018
Effects on Satisfaction and Service Engagement of Paliperidone Palmitate Compared with Oral Paliperidone in Patients with Schizophrenia: An Open Label Randomized Controlled TrialPaola Bozzatello, Silvio Bellino, Irene Mancini, et al.
Clinical Drug Investigation|January 15, 2019
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast CancerGriet Hoste, Laurence Slembrouck, Lynn Jongen, et al.
Clinical Drug Investigation|November 28, 2019
A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare SettingYun Bao, Gang Zhao, Shuli Qu, et al.
Clinical Drug Investigation|January 12, 2020
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled TrialEbrahim Salehifar, Ghasem Janbabaei, Narjes Hendouei, et al.
Clinical Drug Investigation|February 9, 2020
Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European CountriesAndrea Marcellusi, Chiara Bini, Massimo Andreoni, et al.
Clinical Drug Investigation|February 10, 2020
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS StudiesAntonio Pecoraro, Silvia Ricci, Alessandra Vultaggio, et al.
Pageof 234